Literature DB >> 28677496

Metabolic Syndrome, Dyslipidemia and Regulation of Lipoprotein Metabolism.

Jahangir Iqbal1, Ali Al Qarni1, Abbas Hawwari1, Ahmad F Alghanem1, Gasmelseed Ahmed1.   

Abstract

BACKGROUND: Metabolic syndrome is associated with increased risk for both type 2 diabetes and cardiovascular disease. Development of these pathologies is associated with the disorders of lipid and lipoprotein metabolism. Dyslipidemia leads to the overproduction of potentially atherogenic lipid and lipoproteins. Furthermore, there is a decrease in the levels of high-density lipoproteins and an increase in the levels of remnant and small dense LDL particles.
CONCLUSION: In the current review, we have discussed the pathophysiology of lipoprotein biosynthesis and metabolism in the metabolic syndrome. Finally, we describe regulation of lipoprotein metabolism which may be used as a potential target for treating dyslipidemia in metabolic syndrome. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Metabolic syndrome; dyslipidemia; insulin resistance; lipid metabolism; lipoprotein biosynthesis; microRNA.

Mesh：

Substances：

Year:  2018        PMID： 28677496     DOI： 10.2174/1573399813666170705161039

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN： 1573-3998


  19 in total

1.  Developmental programming: Prenatal testosterone-induced changes in epigenetic modulators and gene expression in metabolic tissues of female sheep.

Authors:  Xingzi Guo; Muraly Puttabyatappa; Steven E Domino; Vasantha Padmanabhan
Journal:  Mol Cell Endocrinol       Date:  2020-06-17       Impact factor: 4.102

2.  PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Authors:  Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska
Journal:  Arch Med Sci       Date:  2021-11-08       Impact factor: 3.318

Review 3.  Is Arsenic Exposure a Risk Factor for Metabolic Syndrome? A Review of the Potential Mechanisms.

Authors:  Pablo Pánico; Myrian Velasco; Ana María Salazar; Arturo Picones; Rosa Isela Ortiz-Huidobro; Gabriela Guerrero-Palomo; Manuel Eduardo Salgado-Bernabé; Patricia Ostrosky-Wegman; Marcia Hiriart
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

Review 4.  The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application.

Authors:  Yu Xiang; Li Mao; Mei-Ling Zuo; Gui-Lin Song; Li-Ming Tan; Zhong-Bao Yang
Journal:  Mediators Inflamm       Date:  2022-06-17       Impact factor: 4.529

5.  LRP1-Mediated AggLDL Endocytosis Promotes Cholesteryl Ester Accumulation and Impairs Insulin Response in HL-1 Cells.

Authors:  Virginia Actis Dato; Aleyda Benitez-Amaro; David de Gonzalo-Calvo; Maximiliano Vazquez; Gustavo Bonacci; Vicenta Llorente-Cortés; Gustavo Alberto Chiabrando
Journal:  Cells       Date:  2020-01-10       Impact factor: 6.600

6.  Cross-talk between ANGPTL4 gene SNP Rs1044250 and weight management is a risk factor of metabolic syndrome.

Authors:  Zhoujie Tong; Jie Peng; Hongtao Lan; Wenwen Sai; Yulin Li; Jiaying Xie; Yanmin Tan; Wei Zhang; Ming Zhong; Zhihao Wang
Journal:  J Transl Med       Date:  2021-02-16       Impact factor: 5.531

7.  Health behaviors and metabolic risk factors are associated with dyslipidemia in ethnic Miao Chinese adults: the China multi-ethnic cohort study.

Authors:  Fang Nie; Ziyun Wang; Qibing Zeng; Han Guan; Jingyuan Yang; Peng Luo; Lunwei Du; Junhua Wang; Feng Hong
Journal:  BMC Public Health       Date:  2021-05-03       Impact factor: 3.295

8.  Aberrant expression of HDL-bound microRNA induced by a high-fat diet in a pig model: implications in the pathogenesis of dyslipidaemia.

Authors:  Guoyuan Sui; Lianqun Jia; Nan Song; Dongyu Min; Si Chen; Yao Wu; Guanlin Yang
Journal:  BMC Cardiovasc Disord       Date:  2021-06-06       Impact factor: 2.298

Review 9.  Green Tea Catechins: Their Use in Treating and Preventing Infectious Diseases.

Authors:  Wanda C Reygaert
Journal:  Biomed Res Int       Date:  2018-07-17       Impact factor: 3.411

Review 10.  The potential role of sesquiterpene lactones isolated from medicinal plants in the treatment of the metabolic syndrome - A review.

Authors:  Anuar Salazar-Gómez; Julio C Ontiveros-Rodríguez; Saudy S Pablo-Pérez; M Elena Vargas-Díaz; Leticia Garduño-Siciliano
Journal:  S Afr J Bot       Date:  2020-09-16       Impact factor: 2.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.